The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Changing Physician Incentives for Affordable, Quality Cancer Care: Results of an Episode Payment Model
Abstract
Modifying the current fee-for-service payment system for cancer therapy with feedback data and financial incentives that reward outcomes and cost efficiency resulted in a significant total cost reduction. Eliminating existing financial chemotherapy drug incentives paradoxically increased the use of chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an episode-based payment model demonstrated 34% cost savings by aligning payment incentives with EBPs and reimbursing for enhanced care as compared to a fee-for-service system [46].”
From Translating economic evaluations into financing strategies for implementing evidence-based practices (2021) · cites this paper as [46]
Citations
Cites
How Medicare’s Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment
Jacobson, M., Earle, C. C., Price, M., & Newhouse, J. P. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0563 · Cited by 171
Episode-Based Payment For Cancer Care: A Proposed Pilot For Medicare
Bach, P. B., Mirkin, J. N., & Luke, J. J. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.0752 · Cited by 57
Who Will Have Health Insurance in the Future? An Updated Projection
Young, R. A., & DeVoe, J. E. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1348 · Cited by 56
Newcomer, L. N. (2012) · Health Affairs · doi:10.1377/hlthaff.2012.0002 · Cited by 54
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Dummit, L. A., Kahvecioglu, D. C., Marrufo, G. M., Rajkumar, R., Marshall, J., Tan, E., Press, M. J., Flood, S. M., Muldoon, L., Gu, Q., et al. (2016) · JAMA · doi:10.1001/jama.2016.12717 · Cited by 350
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer
Narang, A. K., & Nicholas, L. H. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4865 · Cited by 221
Value and affordability of CAR T-cell therapy in the United States
Fiorenza, S., Ritchie, D. S., Ramsey, S. D., Turtle, C. J., & Roth, J. A. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0956-8 · Cited by 152
Pfister, D. G., Rubin, D. M., Elkin, E. B., Neill, U. S., Duck, E., Radzyner, M. H., & Bach, P. B. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3151 · Cited by 147
The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology
American Society of Clinical Oncology (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.010462 · Cited by 136
Metadata
- Authors
- Newcomer, L. N., Gould, B., Page, R. D., Donelan, S. A., & Perkins, M.
- Affiliations
- Center for Cancer and Blood Disorders (US)
- Venue
- Journal of Oncology Practice
- Published
- 2014-09
- Volume
- 10
- Issue
- 5
- Pages
- 322-326
- ISSN
- 1554-7477 (ISSN-L)
- 1935-469X
- OpenAlex
- W2110556979
- Cited by
- 128
- References
- 4
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 12 · 2020: 8 · 2019: 14 · 2018: 11 · 2017: 14 · 2016: 28 · 2015: 20 · 2014: 8
- FWCI
- 57.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Oncology Practice (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society of Clinical Oncology
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
- Keywords
- chemotherapy costs, fee-for-service, cost reduction, quality of cancer care, breast cancer, colon cancer, lung cancer
- MeSH terms
- Antineoplastic Agents, Health Expenditures, Humans, Medical Oncology, Neoplasms, Physicians, Quality of Health Care, Registries, Reimbursement, Incentive, Health Care Costs, Outcome Assessment, Health Care, Fee-for-Service Plans, Quality Improvement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
